Dr Cathy O’Hare

Head of US Operations

Cathy has 15 years of experience in translational research, including expertise in clinical biomarker and diagnostic development for NASH and associated metabolic indications. Before joining Perspectum, Cathy led the NASH biomarker development program at Medivation